Access Pharmaceuticals, Inc. · Dallas, TX United States (OTC: ACCP)
| 2600 N. Stemmons Fwy., Ste. 176 | Phone: 214-905-5100 |
| Dallas, TX | Fax: 214-905-5101 |
| 75207 | |
| United States | 
Map This Company |
Access Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Access Pharmaceuticals is developing treatments to tap into the cancer therapy market. The company makes pharmaceutical products based on nanopolymer chemistry and other drug delivery technologies. Its
Access Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: ACCP Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 13 |
Executives
13 executives listed for Access Pharmaceuticals, Inc.'s Dallas, TX location.
| Chairman | Steven Rouhandeh | |
|---|---|---|
| Vice Chairman, Europe and Senior Director, Oncology Clinical Research and Development | Esteban Cvitkovic | |
| CEO and Director; President, SCO Financial Group LLC | Jeffrey Davis |